Trial Profile
Linezolid continuous infusion: optimizing the dosage regimen in critically ill patients through a pharmacokinetic / pharmacodynamic analysis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2020
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections; Critical illness; Gram-positive infections
- Focus Therapeutic Use
- 08 Mar 2016 New trial record